Subscribe or Manage Preferences

Association for Value-Based Cancer Care (AVBCC) Fourth Annual Conference Press Release

Press Releases published on May 1, 2014
Contact: Jini Gopalaswamy
Senior Project Manager
Association for Value-Based Cancer Care, Inc.
Phone: 732-992-1897
E-mail: jgopalaswamy@the-lynx-group.com

For Immediate Release:
April 22, 2014. More than 250 oncology healthcare professionals, practice managers, and managed care executives will convene in Los Angeles, California, May 6-9, 2014, for the Association for Value-Based Cancer Care (AVBCC) Fourth Annual Conference.

The 4-day educational meeting at Loews Hollywood Hotel will be guided by leaders in cancer care, healthcare policy, and managed care. These experts will provide attendees with a thorough understanding of the evolution of the value equation as it relates to cancer therapies. Information shared at this meeting will help attendees improve and sustain their companies and institutions, while improving patient access and quality of cancer care.

“Why is dialogue about the value of cancer care so important? And why does this conference provide a great format for continuing that dialogue? The next 5 years will be a wild and fun ride. While there are many meetings to consider, the AVBCC Conference is unique; it is more open-minded, open-ended, and interactive,” said Michael A. Kolodziej, MD, an AVBCC Conference co-chair and the National Medical Director of Oncology Solutions at Aetna.

“One of the main benefits of coming to the AVBCC conference is networking. You have the opportunity to hear all the different points of view: oncologists, payers, nurses, pharmaceutical executives, and many others. While everyone has an opinion, what you will find is that there are many commonalities,” added conference co-chair Grant Lawless, RPh, MD, FACP, Program Director and Associate Professor at the University of South Carolina.

The conference will showcase more than 20 educational sessions and 15 abstracts, 3 poster award presentations, 3 panel discussions, a special session highlighting value-based care for multiple myeloma (MM), and an exhibit hall featuring more than 15 sponsor booths. Throughout the meeting, participants will access important resources on today’s hot topics, such as healthcare reform, personalized medicine, cancer care risk models, cancer care delivery, and use of big data in oncology care decisions. The special session, titled “Value-Based Strategies for Patients with Multiple Myeloma” and supported by funding from Millennium: The Takeda Oncology Company, will focus on establishing a value-based paradigm for managing patients with MM, including optimal use of cytogenetics; the latest clinical data for existing and emerging MM agents; and expert guidance on incorporating aspects of cost, value, and access in the treatment paradigm for this malignancy.

Each day of the 2014 AVBCC Conference has a unique theme, providing multidisciplinary stakeholders with a rare opportunity to view key aspects of cancer care from expert providers’ and payers’ perspectives.

On Tuesday, May 6, Grant Lawless, RPh, MD, FACP, and Gary M. Owens, MD, will co-chair sessions that showcase “Principles in Value and Market Access.” Targeting product managers, reimbursement specialists, account managers, and marketers, presentations will cover access and reimbursement issues, calculating and communicating oncology product value, new risk models in cancer care, and global trends in cancer management.

Wednesday, May 7, is “Government and Employers Day.” Jayson Slotnik, JD, MPH, and F. Randy Vogenberg, PhD, RPh, will co-chair educational sessions directed toward policymakers and employers. Key topics include the future of healthcare reform; debates regarding cancer care delivery; and innovative insurance, benefit design, and coverage trends.

On Thursday, May 8, sessions will target “Personalized Medicine and Payers.” In presentations that are co-chaired by Michael A. Kolodziej, MD, and Grant Lawless, RPh, MD, FACP, conference attendees will gain insights about the value of personalized therapies and prognostic testing, the role of big data in oncology decision-making, and the impact of personalized medicine in the future of cancer care.

The final conference day, Friday, May 9, is “Oncology Practice Management, Advocacy, and Navigation Day.” Session co-chairs Linda Bosserman, MD, FACP, and Vicki Kennedy, LCSW, will moderate presentations regarding innovations in oncology practice management and care delivery, and share the perspectives of patients, providers, and the healthcare community in value-based cancer care.

Highlights and interviews from the Fourth Annual AVBCC Conference will be featured in an upcoming issue of Value-Based Cancer Care®, the official publication of AVBCC. This journal provides a forum for payers, providers, and the entire oncology team to consider cost-value issues particular to cancer treatments.

About the Association for Value-Based Cancer Care™ (AVBCC); www.avbcconline.org
The mission of AVBCC is to provide a forum for payers, providers, and the entire oncology team to consider and evaluate the cost-value issues particular to cancer treatments and its impact on patient care and outcomes. This unique focus is achieved through discussions and collaborations with those involved in evaluating therapies, treating patients, and paying for care.

AVBCC is the fastest-growing national specialty organization dedicated to improving the care of cancer patients and their quality of life, by discussing, considering, and evaluating the value equation as it relates to new and existing cancer therapies. This organization, which currently consists of more than 500 members, was established to provide a network for payers and oncology healthcare professionals to interact and network to promote optimal care for patients and their families.

About Value-Based Cancer Care® (VBCC); www.valuebasedcancercare.com
VBCC is the official publication of the Association for Value-Based Cancer Care. The journal provides a forum for payers, providers, and the entire oncology team to consider the cost-value issues particular to cancer treatments. This unique focus is achieved through news coverage from major hematology/oncology meetings and the cancer literature, supplemented with commentaries and perspectives from those involved in evaluating therapies, treating patients, and paying for care.
 
Last modified: May 1, 2014
  • American Health & Drug Benefits
  • Academy of Oncology Nurse Navigators
  • JONS
  • Lynx CME
  • The Oncology Nurse
  • Oncology Practice Management
  • Personalized Medicine in Oncology
  • Value-Based Cancer Care

Search